G. Mantile et al., Stable, long-term bacterial production of soluble, dimeric, disulfide-bonded protein pharmaceuticals without antibiotic selection, BIOTECH PR, 16(1), 2000, pp. 17-25
Numerous biopharmaceuticals and other recombinant biotechnology products ar
e made in prokaryotic hosts. However, bacterial production of native, biolo
gically active eukaryotic proteins is rarely possible for disulfide-bonded
and/or multisubunit proteins. We previously described the production of sol
uble, native disulfide-bonded dimeric proteins in the Escherichia coli cyto
plasm (Miele et al., 1990; Mantile et al., 1993). Native, biologically acti
ve proteins with up to six disulfide bonds have been produced with our expr
ession system (Garces et al., 1997). However, plasmid instability during in
duction limited its usefulness. We now report the stable, high-level expres
sion of soluble, disulfide-bonded human uteroglobin without antibiotic sele
ction. We designed a new vector containing a multifunctional stabilization
region that confers complete plasmid stability and increased protein yields
without copy number increases. Recombinant expression remains fully induci
ble after long-term continuous culture in nonselective liquid medium (at le
ast 260 generations). This system may significantly expand the applications
of bacterial expression to recombinant production of soluble, bioactive pr
oteins for biochemical studies and biopharmaceutical/industrial purposes. A
s a result of the very broad activity spectrum of the stabilization region
we selected, its use could be extended to bacterial hosts other than entero
bacteria.